Anti-CD45RO suppresses human immunodeficiency virus type 1 replication in microglia: Role of Hck tyrosine kinase and implications for AIDS dementia

Journal of Virology

Volumn 80, Issue 1, 2006, Pages 62-72

  Kim, Mee Ohk ^a,b   Suh, Hyeon Sook ^a   Si, Qiusheng ^a   Terman, Bruce I ^a   Lee, Sunhee C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CD45RB ANTIGEN; CD45RO ANTIBODY; CD45RO ANTIGEN; HEMATOPOIETIC CELL KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; NEF PROTEIN; PROTEIN SH3; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; CONTROLLED STUDY; DEMENTIA; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LONG TERMINAL REPEAT; MACROPHAGE ACTIVATION; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

AIDS DEMENTIA COMPLEX; ANTIGENS, CD45; CELL LINE; HIV-1; HUMANS; MICROGLIA; PROTEIN KINASE INHIBITORS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-HCK; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33645980955     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.1.62-72.2006     Document Type: Article

References (65)

1. Altin, J. G., and E. K. Sloan. 1997. The role of CD45 and CD45-associated molecules in T cell activation. Immunol. Cell Biol. 75:430-445.
2. Barbeau, B., G. A. Robichaud, J. F. Fortin, and M. J. Tremblay. 2001. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation. J. Immunol. 167:2700-2713.
3. Basadonna, G. P., L. Auersvald, C. Q. Khuong, X. X. Zheng, N. Kashio, D. Zekzer, M. Minozzo, H. Qian, L. Visser, A. Diepstra, A. I. Lazarovits, S. Poppema, T. B. Strom, and D. M. Rothstein. 1998. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc. Natl. Acad. Sci. USA 95:3821-3826.
4. Baur, A., S. Garber, and B. M. Peterlin. 1994. Effects of CD45 on NF-kappa B. Implications for replication of HIV-1. J. Immunol. 152:976-983.
5. Biggs, T. E., S. J. Cooke, C. H. Barton, M. P. Harris, K. Saksela, and D. A. Mann. 1999. Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both hck and MAPK signaling events. J. Mol. Biol. 290:21-35.
6. Blank, N., M. Kriegel, T. Hieronymus, T. Geiler, S. Winkler, J. R. Kalden, and H. M. Lorenz. 2001. CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: inhibition of proliferation without induction of apoptosis. J. Immunol. 166:6034-6040.
7. Briggs, S. D., B. Scholtz, J. M. Jacque, S. Swingler, M. Stevenson, and T. E. Smithgall. 2001. HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J. Biol. Chem. 276:25605-25611.
8. Briggs, S. D., M. Sharkey, M. Stevenson, and T. E. Smithgall. 1997. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272:17899-17902.
9. Brown, A., X. Wang, E. Sawai, and C. Cheng-Mayer. 1999. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex. J. Virol. 73:9899-9907.
10. Byth, K. F., L. A. Conroy, S. Howlett, A. J. Smith, J. May, D. R. Alexander, and N. Holmes. 1996. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J. Exp. Med. 183:1707-1718.
11. Cale, C. M., N. J. Klein, V. Novelli, P. Veys, A. M. Jones, and G. Morgan. 1997. Severe combined immunodeficiency with abnormalities in expression of the common leucocyte antigen, CD45. Arch. Dis. Child. 76:163-164.
12. Cosenza, M., M.-L. Zhao, Q. Si, and S. C. Lee. 2002. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol. 12:442-455.
13. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-234.
14. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
15. Dickson, D. W., and S. C. Lee. 1997. Microglia, p. 165-205. In R. L. Davis and D. M. Robertson (ed.), Textbook of neuropathology. Williams and Wilkins, Baltimore, Md.
16. Dickson, D. W., S. C. Lee, L. Mattiace, S.-H. Yen, and C. F. Brosnan. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
17. D'Oro, U., and J. D. Ashwell. 1999. Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes. J. Immunol. 162:1879-1883.
18. Felber, B. K., and G. N. Pavlakis. 1988. A quantitative bioassay for HIV-1 based on trans-activation. Science 239:184-187.
19. Gehrmann, J., Y. Matsumoto, and G. W. Kreutzberg. 1995. Microglia: intrinsic immune effector cell of the brain. Brain Res. Brain Res. Rev. 20:269-287.
20. Geleziunas, R., W. Xu, K. Takeda, H. Ichijo, and W. C. Greene. 2001. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410:834-838.
21. Genis, P., M. Jett, E. W. Berton, T. Boyle, H. A. Gelbard, K. Dzenko, R. W. Keane, L. Resnick, Y. Mizrachi, D. J. Volsky, L. G. Epstein, and H. E. Gendelman. 1992. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1703-1718.
22. Gonzales, N. R., R. De Pascalis, J. Schlom, and S. V. Kashmiri. 2005. Minimizing the immunogenicity of antibodies for clinical application. Tumour Biol. 26:31-43.
23. Hao, C., L. J. Guilbert, and S. Fedoroff. 1990. Production of colony-stimulating factor-1 (CSF-1) by mouse astroglia in vitro. J. Neurosci. Res. 27:314-323.
24. Hassaine, G., M. Courcoul, G. Bessou, Y. Barthalay, C. Picard, D. Olive, Y. Collette, R. Vigne, and E. Decroly. 2001. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. J. Biol. Chem. 276:16885-16893.
25. Henderson, A. J., and K. L. Calame. 1997. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc. Natl. Acad. Sci. USA 94:8714-8719.
26. Hiipakka, M., P. Huotari, A. Manninen, G. H. Renkema, and K. Saksela. 2001. Inhibition of cellular functions of HIV-1 Nef by artificial SH3 domains. Virology 286:152-159.
27. Irie-Sasaki, J., T. Sasaki, W. Matsumoto, A. Opavsky, M. Cheng, G. Welstead, E. Griffiths, C. Krawczyk, C. D. Richardson, K. Aitken, N. Iscove, G. Koretzky, P. Johnson, P. Liu, D. M. Rothstein, and J. M. Penninger. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409:349-354.
28. Jacque, J. M., B. Fernandez, F. Arenzana-Seisdedos, D. Thomas, F. Baleux, J. L. Virelizier, and F. Bachelerie. 1996. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-κB is needed for persistent viral replication in monocytes. J. Virol. 70:2930-2938.
29. Kim, M. O., Q. Si, J. N. Zhou, R. G. Pestell, C. F. Brosnan, J. Locker, and S. C. Lee. 2002. Interferon-beta activates multiple signaling cascades in primary human microglia. J. Neurochem. 81:1361-1371.
30. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228-232.
31. Kishihara, K., J. Penninger, V. A. Wallace, T. M. Kundig, K. Kawai, A. Wakeham, E. Timms, K. Pfeffer, P. S. Ohashi, M. L. Thomas, et al. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74:143-156.
32. Kitai, R., M. L. Zhao, N. Zhang, L. L. Hua, and S. C. Lee. 2000. Role of MIP-1β and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNβ. J. Neuroimmunol. 110:230-239.
33. Kolson, D. L., E. Lavi, and F. Gonzalez-Scarano. 1998. The effects of human immunodeficiency virus in the central nervous system. Adv. Virus Res. 50:1-47.
34. Komuro, I., Y. Yokota, S. Yasuda, A. Iwamoto, and K. S. Kagawa. 2003. CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPβ represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection. J. Exp. Med. 198:443-453.
35. Kung, C., J. T. Pingel, M. Heikinheimo, T. Klemola, K. Varkila, L. I. Yoo, K. Vuopala, M. Poyhonen, M. Uhari, M. Rogers, S. H. Speck, T. Chatila, and M. L. Thomas. 2000. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat. Med. 6:343-345.
36. Kure, K., K. M. Weidenheim, W. D. Lyman, and D. W. Dickson. 1990. Morphology and distribution of HIV-1-positive microglia in subacute AIDS encephalitis: pattern of involvement resembling a multisystem degeneration. Acta Neuropathol. 80:393-400.
37. Lazarovits, A. I., S. Poppema, Z. Zhang, M. Khandaker, C. E. Le Feuvre, S. K. Singhal, B. M. Garcia, N. Ogasa, A. M. Jevnikar, M. H. White, G. Singh, C. R. Stiller, and R. Z. Zhong. 1996. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 380:717-720.
38. Lee, C. H., B. Leung, M. A. Lemmon, J. Zheng, D. Cowburn, J. Kuriyan, and K. Saksela. 1995. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14:5006-5015.
39. Lee, S. C., and D. W. Dickson. 2005. Common immune pathways of neural injury in neurodegenerative disorders, p. 85-93. In H. E. Gendelman, I. Grant, I. Everall, S. A. Lipton, and S. Swindells (ed.), Neurology of AIDS. Oxford University Press, New York, N.Y.
40. Lee, S. C., W. C. Hatch, W. Liu, W. D. Lyman, Y. Kress, and D. W. Dickson. 1993. Productive infection of human fetal microglia by HIV-1. Am. J. Pathol. 143:1032-1039.
41. Lee, S. C., W. Liu, C. F. Brosnan, and D. W. Dickson. 1992. Characterization of human fetal dissociated CNS cultures with an emphasis on microglia. Lab. Investig. 67:465-475.
42. Lee, S. C., W. Liu, P. Roth, D. W. Dickson, J. W. Berman, and C. F. Brosnan. 1993. Macrophage colony stimulating factor (CSF-1) in astrocytes and microglia: differential regulation by cytokines and LPS and inhibition of class II MHC expression on microglia. J. Immunol. 150:594-604.
43. Lerner, E. C., and T. E. Smithgall. 2002. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo. Nat. Struct. Biol. 9:365-369.
44. Link, D. C., and M. Zutter. 1995. The proto-oncogene c-fgr is expressed in normal mantle zone B lymphocytes and is developmentally regulated during myelomonocytic differentiation in vivo. Blood 85:472-479.
45. Linnemann, T., Y. H. Zheng, R. Mandic, and B. M. Peterlin. 2002. Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. Virology 294:246-255.
46. Lipton, S. A., and H. E. Gendelman. 1995. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:934-940.
47. Liu, J., M.-L. Zhao, C. F. Brosnan, and S. C. Lee. 1996. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1β and IL-1 receptor antagonist. J. Immunol. 157:3569-3576.
48. Masliah, E., M. Mallory, L. Hansen, M. Alford, T. Albright, R. Terry, P. Shapiro, M. Sundsmo, and T. Saitoh. 1991. Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol. (Berlin) 83:12-20.
49. Persidsky, Y., J. Zheng, D. Miller, and H. E. Gendelman. 2000. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J. Leukoc. Biol. 68:413-422.
50. Renkema, G. H., and K. Saksela. 2000. Interactions of HIV-1 NEF with cellular signal transducing proteins. Front. Biosci. 5:D268-D283.
51. Roach, T., S. Slater, M. Koval, L. White, E. D. C. McFarland, M. Okumura, M. Thomas, and E. Brown. 1997. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr. Biol. 7:408-417.
52. Robichaud, G. A., B. Barbeau, J. F. Fortin, D. M. Rothstein, and M. J. Tremblay. 2002. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. J. Biol. Chem. 277:23733-23741.
53. Saksela, K. 1997. HIV-1 Nef and host cell protein kinases. Front. Biosci. 2:d606-d618.
54. Saksela, K., G. Cheng, and D. Baltimore. 1995. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
55. Si, Q., M. O. Kim, M.-L. Zhao, N. R. Landau, H. Goldstein, and S. C. Lee. 2002. Vpr- and Nef- dependent induction of RANTES in microglial cells. Virology 301:342-353.
56. 2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. J. Immunol. 173:3504-3513.
57. Song, X., S. Tanaka, D. Cox, and S. C. Lee. 2004. Fcγ receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J. Leukoc. Biol. 75:1147-1155.
58. Stoletov, K. V., C. Gong, and B. I. Terman. 2004. Nek and Crk mediate distinct VEGF-induced signaling pathways that serve overlapping functions in focal adhesion turnover and integrin activation. Exp. Cell Res. 295:258-268.
59. Suh, H. S., M. O. Kim, and S. C. Lee. 2005. Inhibition of GM-CSF signaling and microglial proliferation by anti-CD45RO: role of Hck tyrosine kinase and PI3K/Akt. J. Immunol. 174:2712-2719.
60. Swingler, S., B. Brichacek, J. M. Jacque, C. Ulich, J. Zhou, and M. Stevenson. 2003. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424:213-219.
61. Tan, J., T. Town, T. Mori, Y. Wu, M. Saxe, F. Crawford, and M. Mullan. 2000. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J. Neurosci. 20:7587-7594.
62. Tan, J., T. Town, and M. Mullan. 2000. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J. Biol. Chem. 275:37224-37231.
63. Townsend, K. P., M. Vendrame, J. Ehrhart, B. Faza, J. Zeng, T. Town, and J. Tan. 2004. CD45 isoform RB as a molecular target to oppose lipopolysaccharide-induced microglial activation in mice. Neurosci. Lett. 362:25-30.
64. Trowbridge, I. S., and M. L. Thomas. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116.
65. Wedel, A., and H. W. Ziegler-Heitbrock. 1995. The C/EBP family of transcription factors. Immunobiology 193:171-185.